MedPath

PMS-FLURAZEPAM CAP 30MG

PMS-FLURAZEPAM CAP 30MG

Discontinued
DIN Number

00667099

Drug Class

Human

Market Date

Dec 31, 1986

Company
HC

Pharmascience Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00667099
AIG Number0108704001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD01 FLURAZEPAM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLURAZEPAM HYDROCHLORIDEActive
Strength: 30 MG / CAP
Monograph: FLURAZEPAM HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.